These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9328480)

  • 21. The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts.
    Polito L; Kehoe PG; Davin A; Benussi L; Ghidoni R; Binetti G; Quadri P; Lucca U; Tettamanti M; Clerici F; Bagnoli S; Galimberti D; Nacmias B; Sorbi S; Guaita A; Scarpini E; Mariani C; Forloni G; Albani D
    Alzheimers Dement; 2013 Jul; 9(4):392-9. PubMed ID: 22651940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
    Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
    J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The relation between alpha1-antichymotrypsin gene polymorphism and epsilon4 allele of apolipoprotein E gene in Alzheimer disease in Chinese].
    Tang G; Jiang S; Gu N; Jin T; Lin S; Qian Y; Wang D; Zhang M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Apr; 16(2):94-6. PubMed ID: 10194255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.
    Agarwal R; Tripathi CB
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of brain activation in people at risk for Alzheimer's disease.
    Bookheimer SY; Strojwas MH; Cohen MS; Saunders AM; Pericak-Vance MA; Mazziotta JC; Small GW
    N Engl J Med; 2000 Aug; 343(7):450-6. PubMed ID: 10944562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.
    Kim HC; Kim DK; Choi IJ; Kang KH; Yi SD; Park J; Park YN
    Psychiatry Clin Neurosci; 2001 Apr; 55(2):115-20. PubMed ID: 11285089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease.
    Combarros O; García-Román M; Fontalba A; Fernández-Luna JL; Llorca J; Infante J; Berciano J
    Dement Geriatr Cogn Disord; 2003; 15(3):151-4. PubMed ID: 12584430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of apolipoprotein E4 isoform in Alzheimer's disease in Poland.
    Bratosiewicz-Zapart J; Kłoszewska I; Sobów T; Liberski PP
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):221-2. PubMed ID: 9597090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E epsilon4 allele frequency in vascular dementia.
    Davidson Y; Gibbons L; Purandare N; Byrne J; Hardicre J; Wren J; Payton A; Pendleton N; Horan M; Burns A; Mann DM
    Dement Geriatr Cogn Disord; 2006; 22(1):15-9. PubMed ID: 16645276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
    Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
    Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
    Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
    Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E allele distribution in parents of Down's syndrome children.
    Avramopoulos D; Mikkelsen M; Vassilopoulos D; Grigoriadou M; Petersen MB
    Lancet; 1996 Mar; 347(9005):862-5. PubMed ID: 8622392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease.
    Wang PN; Liu HC; Liu TY; Chu A; Hong CJ; Lin KN; Chi CW
    Dement Geriatr Cogn Disord; 2005; 19(2-3):120-5. PubMed ID: 15591802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease.
    Suh GH; Jung HY; Lee CU; Oh BH; Lee SK; Lee N; Kim J; Kee BS; Ko D; Kim YH; Ju YS; Hong I; Choi S;
    Dement Geriatr Cogn Disord; 2006; 21(1):33-9. PubMed ID: 16254428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APOE and modulation of Alzheimer's and frontotemporal dementia.
    Boccardi M; Sabattoli F; Testa C; Beltramello A; Soininen H; Frisoni GB
    Neurosci Lett; 2004 Feb; 356(3):167-70. PubMed ID: 15036621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow.
    Høgh P; Knudsen GM; Kjaer KH; Jørgensen OS; Paulson OB; Waldemar G
    J Geriatr Psychiatry Neurol; 2001; 14(1):42-51. PubMed ID: 11281316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.